Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Altar

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2000
BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brainL A Mamounas, C A Altar, M E Blue, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1988
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonistsC A Altar, W C Boyar, A Wasley, et al.
The European Journal of Neuroscience|September 1, 1994
In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3C A Altar, J A Siuciak, P Wright, et al.
Cell Transplantation|March 1, 1996
Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degenerationW R Galpern, D M Frim, S B Tatter, et al.
Neuropharmacology|December 19, 2001
Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523K Tottori, T Miwa, Y Uwahodo, et al.
Life Sciences|August 25, 1986
CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective dosesC A Altar, A M Wasley, J Liebman, et al.
The Pharmacogenomics Journal|February 18, 2015
Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypesC A Altar, J M Carhart, J D Allen, et al.
The European Journal of Neuroscience|February 1, 1996
Neurotrophin-4/5 maintains the cholinergic phenotype of axotomized septal neuronsR F Alderson, S J Wiegand, K D Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivoC A Altar, C B Boylan, C Jackson, et al.
The Journal of Comparative Neurology|June 26, 1995
Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptorsK D Anderson, R F Alderson, C A Altar, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2000
BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brainL A Mamounas, C A Altar, M E Blue, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1988
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonistsC A Altar, W C Boyar, A Wasley, et al.
The European Journal of Neuroscience|September 1, 1994
In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3C A Altar, J A Siuciak, P Wright, et al.
Cell Transplantation|March 1, 1996
Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degenerationW R Galpern, D M Frim, S B Tatter, et al.
Neuropharmacology|December 19, 2001
Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523K Tottori, T Miwa, Y Uwahodo, et al.
Life Sciences|August 25, 1986
CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective dosesC A Altar, A M Wasley, J Liebman, et al.
The Pharmacogenomics Journal|February 18, 2015
Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypesC A Altar, J M Carhart, J D Allen, et al.
The European Journal of Neuroscience|February 1, 1996
Neurotrophin-4/5 maintains the cholinergic phenotype of axotomized septal neuronsR F Alderson, S J Wiegand, K D Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivoC A Altar, C B Boylan, C Jackson, et al.
The Journal of Comparative Neurology|June 26, 1995
Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptorsK D Anderson, R F Alderson, C A Altar, et al.
Pageof 10